Skip to content
Trial Eligibility
Menu

The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD

NCT07667309

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Participants in this study will have already been enrolled in another research study: Combining Stellate Ganglion Block with Prolonged Exposure for PTSD, NCT05889741. The investigators are using a Sleep Profiler, EEG headband to monitor a participants brainwaves while they sleep to see what effects the Stellate Ganglion Block injection has on their sleep. Participants will wear the headband for 3 nights before the injection and then 3 nights after the injection. Participants will also complete self-report questionnaires regarding their sleep prior to the injection and following the injection.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Post Traumatic Stress Disorder PTSD

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
The University of Texas Health Science Center at San Antonio
Last updated on ClinicalTrials.gov
October 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 2

  • Carl R. Darnall Army Medical Center at Fort Hood · Killeen, TX
  • University of Texas Health Science Center at San Antonio · San Antonio, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.